Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Correction to: Adv Ther (2020) 37:4033–4042 10.1007/s12325-020-01449-0 In the original article, there is an error in Fig. 1. The correct Fig. 1 is given below: Fig. 1 SVR12 rates in TN patients with CC, GT1–6a treated with 8 weeks of G/P. aScottish HCV study included GT1,2,4–6, US VA study included GT1–3. bFour patients were lost to follow-up in the ITT population. cOne confirmed reinfection with subsequent spontaneous clearance, no virologic failure. dOne virologic failure. eOne patient died after completing treatment but before SVR12 testing, one patient was lost to follow-up. fPatients missing SVR12 data were excluded from SVR12 analysis. CC compensated cirrhosis, DHC-R German Hepatitis C-Registry, G/P glecaprevir/pibrentasvir, GT genotype, HCV hepatitis C virus, ITT intention-to-treat, PMOS post-marketing observational studies, SVR12 sustained virologic response at week 12, TN treatment-naïve, VA Veterans Association

Related collections

Author and article information

Contributors

Pietro Lampertico:

ORCID: http://orcid.org/0000-0002-1026-7476

pietro.lampertico@unimi.it

Journal

Journal ID (nlm-ta): Adv Ther

Journal ID (iso-abbrev): Adv Ther

Title: Advances in Therapy

Publisher: Springer Healthcare (Cheshire )

ISSN (Print): 0741-238X

ISSN (Electronic): 1865-8652

Publication date (Electronic): 11 September 2020

Publication date PMC-release: 11 September 2020

Publication date (Print): 2020

Volume: 37

Issue: 11

Pages: 4755-4756

Affiliations

[1 ]GRID grid.414818.0, ISNI 0000 0004 1757 8749, Division of Gastroenterology and Hepatolgy, CRC “A.M. and A.Migliavacca” Center for Liver Disease, , Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, ; Milan, Italy

[2 ]GRID grid.4708.b, ISNI 0000 0004 1757 2822, Department of Pathophysiology and Transplantation, , University of Milan, ; Milan, Italy

[3 ]GRID grid.417595.b, Center for HIV and Hepatogastroenterology, ; Düsseldorf, Germany

[4 ]GRID grid.11780.3f, ISNI 0000 0004 1937 0335, Internal Medicine and Hepatology Unit, , University of Salerno, ; Salerno, Italy

[5 ]GRID grid.5214.2, ISNI 0000 0001 0669 8188, Department of Life Sciences, , Glasgow Caledonian University, ; Glasgow, UK

[6 ]GRID grid.411714.6, ISNI 0000 0000 9825 7840, Gastroenterology, Glasgow Royal Infirmary, ; Glasgow, UK

[7 ]GRID grid.431072.3, ISNI 0000 0004 0572 4227, AbbVie Inc., ; North Chicago, IL USA

[8 ]GRID grid.467162.0, ISNI 0000 0004 4662 2788, AbbVie Deutschland GmBH Co. KG, ; Wiesbaden, Germany

[9 ]GRID grid.10025.36, ISNI 0000 0004 1936 8470, University of Liverpool Hepatology Drug Interactions Group, ; Liverpool, UK

[10 ]GRID grid.280747.e, ISNI 0000 0004 0419 2556, Department of Veterans Affairs, , VA Palo Alto Healthcare System, ; Palo Alto, CA USA

[11 ]GRID grid.410718.b, ISNI 0000 0001 0262 7331, Department of Gastroenterology and Hepatology, , Essen University Hospital, ; Essen, Germany

[12 ]Leberstiftungs-GmbH Deutschland, Hannover, Germany

[13 ]GRID grid.10423.34, ISNI 0000 0000 9529 9877, Department of Gastroenterology, Hepatology and Endocrinology, , Hannover Medical School, ; Hannover, Germany

[14 ]GRID grid.16753.36, ISNI 0000 0001 2299 3507, Northwestern University Feinberg School of Medicine, ; Chicago, IL USA

Author information

Pietro Lampertico http://orcid.org/0000-0002-1026-7476

Article

Publisher ID: 1482

DOI: 10.1007/s12325-020-01482-z

PMC ID: 7547987

PubMed ID: 32915409

SO-VID: c3a1bc25-9a79-4850-a55c-faf1d792ef4f

License:

Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

History

Custom metadata

Data availability:

Comments

Comment on this article

scite_